Drägerwerk AG & Co. KGaA/€DRW8
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA, headquartered in Lübeck, Germany, operates in the medical and safety technology industries. The company's core business revolves around the production of medical equipment such as anesthesia workstations, ventilators, and patient monitoring systems, as well as safety products including personal protective equipment and gas detection technology. Founded in 1889, Drägerwerk has a substantial international presence, with markets across Europe, the Americas, Asia-Pacific, and Africa. The company's competitive strength lies in its longstanding expertise in combining engineering with innovation to meet complex regulatory and operational demands in healthcare and industrial safety sectors.
Ticker
€DRW8
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
16,615
ISIN
DE0005550602
Website
DRW8 Metrics
BasicAdvanced
€1.1B
-
-
0.38
€1.97
3.56%
Price and volume
Market cap
€1.1B
Beta
0.38
52-week high
€59.00
52-week low
€49.30
Dividend rate
€1.97
Financial strength
Current ratio
1.815
Quick ratio
0.97
Long term debt to equity
15.717
Total debt to equity
23.232
Dividend payout ratio (TTM)
28.77%
Interest coverage (TTM)
8.22%
Profitability
EBITDA (TTM)
231.845
Gross margin (TTM)
44.97%
Net profit margin (TTM)
3.42%
Operating margin (TTM)
4.43%
Effective tax rate (TTM)
28.79%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
3.06%
Return on equity (TTM)
7.78%
Valuation
Dividend yield (TTM)
3.56%
Forward dividend yield
3.56%
Growth
Revenue change (TTM)
0.51%
3-year revenue growth (CAGR)
1.84%
10-year revenue growth (CAGR)
3.15%
3-year dividend per share growth (CAGR)
120.25%
10-year dividend per share growth (CAGR)
3.86%
Bulls say / Bears say
Drägerwerk AG & Co. KGaA reported a significant increase in net sales for fiscal year 2023, growing by approximately 13% to €3,373.5 million, indicating strong market demand and operational efficiency. (finanzwire.com)
The company improved its earnings before interest and taxes (EBIT) to around €166 million in 2023, a substantial rise from the previous year's negative results, showcasing effective cost management and profitability enhancement. (finanzwire.com)
Drägerwerk increased its dividend for 2023 to €1.74 per common share and €1.80 per preferred share, reflecting confidence in its financial health and commitment to shareholder returns. (finanzwire.com)
In the first quarter of 2025, Drägerwerk's EBIT plummeted from €15.1 million in the previous year to €0.4 million, attributed to lower sales volumes and higher costs, raising concerns about short-term profitability. (marketscreener.com)
The medical division experienced a decline in net sales by 2.6% (net of currency effects) to around €1,900 million in 2024, primarily due to challenging market conditions in China, indicating potential regional vulnerabilities. (marketscreener.com)
Despite a positive outlook, Drägerwerk's forecast for 2024 anticipates a modest net sales increase of 1.0 to 5.0% and an EBIT margin of 2.5 to 5.5%, suggesting limited growth potential in the near term. (finanzwire.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Drägerwerk AG & Co. KGaA stock?
Drägerwerk AG & Co. KGaA (DRW8) has a market cap of €1.1B as of June 30, 2025.
What is the P/E ratio for Drägerwerk AG & Co. KGaA stock?
The price to earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DRW8) stock is 0 as of June 30, 2025.
Does Drägerwerk AG & Co. KGaA stock pay dividends?
Yes, the Drägerwerk AG & Co. KGaA (DRW8) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is €1.97 and the yield is 3.56%. Drägerwerk AG & Co. KGaA has a payout ratio of 28.77% on a trailing twelve-month basis.
When is the next Drägerwerk AG & Co. KGaA dividend payment date?
The next Drägerwerk AG & Co. KGaA (DRW8) dividend payment date is unconfirmed.
What is the beta indicator for Drägerwerk AG & Co. KGaA?
Drägerwerk AG & Co. KGaA (DRW8) has a beta rating of 0.38. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.